Jazz Pharmaceuticals UK Holdings Limited,(the “Issuer”) is a company incorporated in England and Wales on 21 January 2021 with registration number 13150429 and is an indirect wholly owned subsidiary of Jazz Pharmaceuticals Plc (the “Parent”).Jazz Pharmaceuticals Plc “Jazz Group”- is an international biopharmaceutical group focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. Jazz Pharmaceuticals Plc is a public limited company formed under the laws of Ireland (registered number 399192) and is the ultimate parent company to the Jazz Pharmaceuticals group of companies.
Jazz Pharmaceuticals UK Holdings Limited US$2,960,000,000 - 4.6% Fixed Rate Note due 15 January 2029.
Copyright © 2023 by the Bermuda Stock Exchange. All rights reserved!
Any questions or requests for information can be emailed to info@bsx.com